What's new

[Cyprus Times] New HIV strain in Cyprus discovered by the Kostriki team

kostrikis.jpg

The results of this discovery were published by the prestigious international medical journal Virulence

Scientists from the University of Cyprus and the HIV National Laboratory in Los Alamos, New Mexico, United States of America have discovered a new strain of recombinant human immunodeficiency virus type 1 (HIV-1), named CRF91_cpx.

The genome of the new recombinant strain is a mosaic of four strains of HIV-1: CRF02_AG, G, J and U. The results of this discovery were published on 18 August 2022 by the prestigious international medical journal Virulence (Taylor & Francis, UK) https:/doi.org/10.1080/21505594.2022.2106021

Viruses are tiny infectious particles that can only replicate inside a host cell. They infect the living cells of an organism and take over the host cell's mechanisms to multiply. Some viruses are known to cause disease in humans, which has led to many infectious disease pandemics over the years.

Emerging and re-emerging human viral infectious diseases are an ever-growing public health threat with devastating socioeconomic consequences of global proportions.

HIV-1 is among these viruses and is known to cause the life-threatening Acquired Immunodeficiency Syndrome (AIDS) that became a global pandemic in 1981. Unlike most global epidemics, the HIV-1/AIDS epidemic has persisted for more than 40 years and continues to be a global health threat to this day.

What is HIV-1

HIV-1 is a retrovirus that attacks the body's immune system leading to AIDS. According to the World Health Organization (WHO), since the beginning of the epidemic, approximately 79.3 million people have been infected with HIV-1 and nearly 36.3 million people have died from AIDS-related illnesses. Over the past twenty years, combination antiretroviral drug therapy (cART) has been developed to specifically target HIV-1 with outstanding success, resulting in a dramatic reduction in mortality among people infected with HIV-1. However, the rapid genetic variability of HIV-1 presents the most striking challenge to effectively treating HIV-1 infection and creating a protective vaccine against viral transmission.



What is the situation in Cyprus?

Molecular research conducted at the University of Cyprus in collaboration with the Gregory AIDS Clinic of Larnaca General Hospital has led to the discovery of a novel recombinant/chimeric HIV-1 strain, consisting of four different strains: CRF02_AG, G, J and U (U is an unknown subtype, which does not belong to any established subtype). This new recombinant HIV-1 strain was classified as a new Circulating Recombinant Form (CRF) of HIV-1 and was named "CRF91_cpx" by the HIV Databases of Los Alamos National Laboratory (USA).

CRF91_cpx was discovered among 14 people with HIV-1 residing in Cyprus.

CRF91_cpx was discovered among 14 people with HIV-1 residing in Cyprus. Currently, epidemiological analyses indicate that the CRF91_cpx strain is circulating mainly among Cypriot men who have sex with men (MSM) infected in Cyprus. Following the initial discovery, ongoing phylogenetic analyses conducted with HIV-1 strain genomes isolated from newly diagnosed patients in Cyprus in near real-time have identified two more Cypriot MSM who were infected with the CRF91_cpx strain. The data suggest an ongoing transmission of this novel recombinant HIV-1 strain, CRF91_cpx, in Cyprus with currently unknown clinical manifestations.

Which scientists made this important discovery

The discovery was made by scientists Çiçek Topçu and Vassilis Georgiou of the Laboratory of Molecular Virology, Department of Biological Sciences, University of Cyprus, led by Academic Professor Leontios Kostrikis and Dr. Brian Thomas Foley of the HIV National Laboratory of Los Alamos, New Mexico, United States of America.

It is worth noting that the discovery is part of the Ph.D. thesis of Ms. Çiçek Topçu and the M.Sc. thesis of Mr. Vassilis Georgiou of the Molecular Virology Laboratory of the University of Cyprus. The results of this discovery were published on 18 August 2022 by the distinguished international medical journal Virulence1

https:/doi.org/10.1080/21505594.2022.2106021

< >Topcu C., Georgiou V., Hezka Rodosthenous J., Demetriades I., Foley B.T., and Kostrikis L.G. Characterization of a Novel HIV-1 Circulating Recombinant Form, CRF91_cpx, Comprising CRF02_AG, G, J, and U, Mostly Among Men Who Have Sex with Men. virulence 13(1):1331-1348 (doi.org/10.1080/21505594.2022.2106021), 2022


Contents of this article including associated images are belongs to Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times

Source
 
Back
Top